We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

MFG:NYSEMizuho Financial Group, Inc. Sponosred Analysis

Data as of 2026-04-17 - not real-time

$8.63

Latest Price

5/10Risk

Risk Level: Medium

Executive Summary

Mizuho Financial Group (MFG) is trading at $8.63, comfortably above its 20‑day ($8.18) and 50‑day ($8.55) simple moving averages, while still below the identified resistance at $8.87. Technical signals are mixed: the RSI sits at 57, indicating neutral‑to‑slightly bullish momentum, and the MACD histogram is positive, supporting a bullish bias, yet the overall trend is labeled neutral and volume has been decreasing, suggesting a potential pause. Market sentiment is unusually optimistic, reflected by an “Extreme Greed” reading on the Fear & Greed Index, but short interest remains minimal at 0.04% of float, implying limited downside pressure.
From a valuation perspective, MFG’s trailing PE of 16.3 is below the industry average of 17.5, and its price‑to‑book ratio of 0.30 is exceptionally low, pointing to an undervalued position. Forward earnings expectations are compelling, with a forward PE of just 6.2, while the dividend yield of 2.28% and a modest 34.8% payout ratio suggest a sustainable income stream. Revenue growth of 5.5% and a 9.6% ROE provide a modest growth backdrop, reinforcing a blended growth‑value case.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Price near resistance with decreasing volume
  • Neutral overall trend despite bullish MACD
  • Low short interest limiting upside

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • Undervalued multiples relative to peers
  • Attractive forward PE and sustainable dividend
  • Steady revenue growth and improving profitability

Long Term

> 3 years
Positive
Model confidence: 8/10

Key Factors

  • Strong balance sheet with cash exceeding debt
  • Consistent dividend payout and low payout ratio
  • Diversified global operations reducing concentration risk

Key Metrics & Analysis

Financial Health

Revenue Growth5.50%
Profit Margin26.13%
P/E Ratio16.3
ROE9.65%
ROA0.36%
P/B Ratio0.3
Industry P/E17.5

Technical Analysis

TrendNeutral
RSI57.3
Support$7.54
Resistance$8.87
MA 20$8.18
MA 50$8.55
MA 200$7.23
MACDBullish
VolumeDecreasing
Fear & Greed Index89.39

Valuation

Target Price$8.45
Upside/Downside-2.06%
GradeUndervalued
TypeBlend
Dividend Yield2.28%

Risk Assessment

Beta0.99
Volatility37.87%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.